Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients
View ORCID ProfileJessica Bassi, View ORCID ProfileOlivier Giannini, Chiara Silacci-Fregni, Laura Pertusini, Paolo Hitz, Tatiana Terrot, Yves Franzosi, Francesco Muoio, Christian Saliba, Marcel Meury, Exequiel A. Dellota Jr., Josh Dillen, Patrick Hernandez, View ORCID ProfileNadine Czudnochowski, Elisabetta Cameroni, Nicola Beria, Mariangela Ventresca, Alberto Badellino, Soraya Lavorato-Hadjeres, Elisabetta Lecchi, Tecla Bonora, Matteo Mattiolo, Guido Trinci, Daniela Garzoni, Giuseppe Bonforte, Valentina Forni-Ogna, Davide Giunzioni, Lorenzo Berwert, View ORCID ProfileRavindra K. Gupta, View ORCID ProfilePaolo Ferrari, View ORCID ProfileAlessandro Ceschi, View ORCID ProfilePietro Cippà, View ORCID ProfileDavide Corti, View ORCID ProfileAntonio Lanzavecchia, View ORCID ProfileLuca Piccoli
doi: https://doi.org/10.1101/2021.10.05.21264054
Jessica Bassi
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland
Olivier Giannini
2Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland
3Department of Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
Chiara Silacci-Fregni
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland
Laura Pertusini
4Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland
Paolo Hitz
2Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland
Tatiana Terrot
5Clinical Trial Unit, Ente Ospedaliero Cantonale, Lugano, Switzerland
Yves Franzosi
5Clinical Trial Unit, Ente Ospedaliero Cantonale, Lugano, Switzerland
Francesco Muoio
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland
Christian Saliba
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland
Marcel Meury
6Vir Biotechnology, San Francisco, California, United States of America
Exequiel A. Dellota Jr.
6Vir Biotechnology, San Francisco, California, United States of America
Josh Dillen
6Vir Biotechnology, San Francisco, California, United States of America
Patrick Hernandez
6Vir Biotechnology, San Francisco, California, United States of America
Nadine Czudnochowski
6Vir Biotechnology, San Francisco, California, United States of America
Elisabetta Cameroni
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland
Nicola Beria
4Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland
Mariangela Ventresca
4Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland
Alberto Badellino
4Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland
Soraya Lavorato-Hadjeres
4Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland
Elisabetta Lecchi
4Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland
Tecla Bonora
4Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland
Matteo Mattiolo
4Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland
Guido Trinci
4Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland
Daniela Garzoni
4Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland
Giuseppe Bonforte
4Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland
Valentina Forni-Ogna
4Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland
Davide Giunzioni
4Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland
Lorenzo Berwert
4Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland
Ravindra K. Gupta
7Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
8Department of Medicine, University of Cambridge, Cambridge, United Kingdom
Paolo Ferrari
2Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland
4Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland
9Clinical School, University of New South Wales, Sydney, Australia
Alessandro Ceschi
2Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland
5Clinical Trial Unit, Ente Ospedaliero Cantonale, Lugano, Switzerland
10Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Science of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland
11Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Zurich, Switzerland
Pietro Cippà
3Department of Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
4Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland
12Faculty of Medicine, University of Zurich, Zurich, Switzerland
Davide Corti
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland
Antonio Lanzavecchia
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland
Luca Piccoli
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland
Article usage
Posted December 18, 2021.
Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients
Jessica Bassi, Olivier Giannini, Chiara Silacci-Fregni, Laura Pertusini, Paolo Hitz, Tatiana Terrot, Yves Franzosi, Francesco Muoio, Christian Saliba, Marcel Meury, Exequiel A. Dellota Jr., Josh Dillen, Patrick Hernandez, Nadine Czudnochowski, Elisabetta Cameroni, Nicola Beria, Mariangela Ventresca, Alberto Badellino, Soraya Lavorato-Hadjeres, Elisabetta Lecchi, Tecla Bonora, Matteo Mattiolo, Guido Trinci, Daniela Garzoni, Giuseppe Bonforte, Valentina Forni-Ogna, Davide Giunzioni, Lorenzo Berwert, Ravindra K. Gupta, Paolo Ferrari, Alessandro Ceschi, Pietro Cippà, Davide Corti, Antonio Lanzavecchia, Luca Piccoli
medRxiv 2021.10.05.21264054; doi: https://doi.org/10.1101/2021.10.05.21264054
Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients
Jessica Bassi, Olivier Giannini, Chiara Silacci-Fregni, Laura Pertusini, Paolo Hitz, Tatiana Terrot, Yves Franzosi, Francesco Muoio, Christian Saliba, Marcel Meury, Exequiel A. Dellota Jr., Josh Dillen, Patrick Hernandez, Nadine Czudnochowski, Elisabetta Cameroni, Nicola Beria, Mariangela Ventresca, Alberto Badellino, Soraya Lavorato-Hadjeres, Elisabetta Lecchi, Tecla Bonora, Matteo Mattiolo, Guido Trinci, Daniela Garzoni, Giuseppe Bonforte, Valentina Forni-Ogna, Davide Giunzioni, Lorenzo Berwert, Ravindra K. Gupta, Paolo Ferrari, Alessandro Ceschi, Pietro Cippà, Davide Corti, Antonio Lanzavecchia, Luca Piccoli
medRxiv 2021.10.05.21264054; doi: https://doi.org/10.1101/2021.10.05.21264054
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)